Drug1 | Resistance | Supporting Mutations (frequency) |
Isoniazid | ||
Rifampicin | ||
Ethambutol | ||
Pyrazinamide | ||
Streptomycin | ||
Ethionamide | ||
Fluoroquinolones | ||
Amikacin | ||
Capreomycin | ||
Kanamycin |
Lineage2 | Family | Main Spoligotype | RDS |
lineage4 | Euro-American | LAM;T;S;X;H | None |
lineage4.6 | Euro-American | T;LAM | None |
lineage4.6.2 | Euro-American | T;LAM | RD726 |
lineage4.6.2.2 | Euro-American (Cameroon) | LAM10-CAM | RD726 |
Gene | Chromosome Position | Mutation | Estimated fraction |
gyrA | 7362 | p.Glu21Gln | 1.000 |
gyrA | 7585 | p.Ser95Thr | 1.000 |
gyrA | 9304 | p.Gly668Asp | 1.000 |
rpsL | 781395 | c.-165T>C | 1.000 |
rrs | 1472172 | r.327t>c | 0.183 |
rrs | 1472181 | r.336g>a | 0.168 |
rrs | 1472214 | r.369c>g | 0.228 |
rrs | 1472235 | r.390g>c | 0.198 |
rrs | 1472240 | r.395g>c | 0.190 |
rrs | 1472242 | r.397c>t | 0.186 |
rrs | 1472251 | r.406g>a | 0.148 |
rrs | 1472253 | r.408g>t | 0.152 |
rrs | 1472259 | r.414c>a | 0.154 |
rrs | 1472266 | r.421c>a | 0.144 |
rrs | 1472338 | r.493a>c | 0.204 |
rrs | 1472344 | r.499c>t | 0.224 |
rrs | 1472349 | r.504a>t | 0.240 |
rrs | 1472374 | r.529t>a | 0.228 |
rrs | 1472379 | r.534t>g | 0.231 |
rrs | 1472382 | r.537g>t | 0.237 |
rrs | 1472391 | r.546c>t | 0.224 |
rrs | 1472598 | r.753a>t | 0.186 |
rrs | 1472616 | r.771g>a | 0.248 |
rrs | 1472734 | r.889c>t | 0.202 |
rrs | 1472741 | r.896g>a | 0.189 |
rrs | 1472742 | r.897c>t | 0.212 |
rrs | 1472781 | r.936c>t | 0.216 |
rrs | 1472793 | r.948a>t | 0.216 |
rrs | 1472803 | r.958t>a | 0.200 |
rrs | 1472812 | r.967a>c | 0.197 |
rrs | 1472887 | r.1042g>c | 0.236 |
rrs | 1473038 | r.1193a>c | 0.252 |
rrs | 1473044 | r.1199c>g | 0.241 |
rrs | 1473173 | r.1328c>t | 0.185 |
rrs | 1473177 | r.1332g>a | 0.238 |
rrs | 1473202 | r.1357c>t | 0.250 |
rrl | 1474199 | r.542g>a | 0.170 |
rrl | 1474201 | r.544t>c | 0.170 |
rrl | 1474202 | r.545t>a | 0.170 |
rrl | 1474218 | r.561t>a | 0.224 |
rrl | 1474228 | r.571t>c | 0.190 |
rrl | 1474235 | r.578g>c | 0.174 |
rrl | 1474249 | r.592g>t | 0.168 |
rrl | 1474252 | r.595t>a | 0.162 |
rrl | 1474264 | r.607t>g | 0.160 |
rrl | 1474265 | r.608g>a | 0.160 |
rrl | 1475526 | r.1869c>t | 0.174 |
rrl | 1475538 | r.1881t>c | 0.135 |
rrl | 1475539 | r.1882a>t | 0.141 |
rrl | 1475540 | r.1883c>t | 0.141 |
rrl | 1475545 | r.1888t>g | 0.137 |
rrl | 1475571 | r.1914a>t | 0.168 |
rrl | 1475707 | r.2050t>c | 0.148 |
rrl | 1475713 | r.2056c>g | 0.150 |
rrl | 1475716 | r.2059a>t | 0.144 |
rrl | 1475803 | r.2146t>c | 0.224 |
rrl | 1475804 | r.2147g>c | 0.224 |
rrl | 1475816 | r.2159c>g | 0.248 |
rrl | 1475817 | r.2160a>g | 0.250 |
rrl | 1476252 | r.2595t>g | 0.140 |
rrl | 1476260 | r.2603a>g | 0.137 |
rrl | 1476266 | r.2609g>a | 0.140 |
rrl | 1476336 | r.2679c>g | 0.214 |
rrl | 1476356 | r.2699c>g | 0.208 |
rrl | 1476357 | r.2700t>a | 0.222 |
rrl | 1476358 | r.2701t>c | 0.176 |
rrl | 1476382 | r.2725a>g | 0.195 |
rrl | 1476384 | r.2727g>t | 0.204 |
rrl | 1476404 | r.2747g>a | 0.209 |
rrl | 1476408 | r.2751g>a | 0.261 |
rrl | 1476442 | r.2785t>a | 0.210 |
rrl | 1476443 | r.2786g>t | 0.225 |
rrl | 1476455 | r.2798c>a | 0.191 |
rrl | 1476456 | r.2799a>t | 0.189 |
rrl | 1476466 | r.2809c>t | 0.214 |
rrl | 1476470 | r.2813c>t | 0.222 |
rrl | 1476474 | r.2817c>t | 0.184 |
rrl | 1476481 | r.2824t>c | 0.188 |
tlyA | 1917972 | c.33A>G | 1.000 |
thyX | 3067474 | p.Pro158Ala | 1.000 |
alr | 3841662 | c.-242A>G | 0.217 |
alr | 3841663 | c.-243G>A | 0.214 |
embC | 4242643 | c.2781C>T | 1.000 |
embB | 4246584 | p.Arg24Pro | 0.600 |
ethA | 4326739 | c.735G>C | 1.000 |
ethR | 4328004 | c.456G>A | 1.000 |
TBProfiler Version: 2.1.1
Analysis | Program |
Mapping | bwa |
Variant Calling | BCFtools |
Drug1 | Sensitivity (%) | Specificity (%) |
Isoniazid | 92.8 (89.9-95.7) | 100 (100-100) |
Rifampicin | 96.2 (93.9-98.5) | 98.1 (96.8-99.4) |
Ethambutal | 88.7 (83.6-93.8) | 81.7 (77.6-85.8) |
Pyrazinamide | 70.9 (62.4-79.4) | 93.9 (90.6-97.2) |
Streptomycin | 87.1 (82.7-91.5) | 89.7 (86.0-93.4) |
Ethionamide | 73.6 (66.7-80.5) | 93.3 (89.6-97.0) |
Moxifloxacin | 60.0 (29.6-90.4) | 68.7 (52.6-84.8) |
Ofloxacin | 85.5 (79.1-91.9) | 94.9 (91.8-98.0) |
Amikacin | 82.9 (74.4-91.4) | 98.3 (96.0-100) |
Capreomycin | 60.7 (50.6-70.8) | 90.7 (87.2-94.2) |
Kanamycin | 87.3 (81.3-93.3) | 93.4 (89.9-96.9) |
Para-aminosalisylic acid | Not determined | Not determined |
Linezolid | Not determined | Not determined |
Clofazimine | Not determined | Not determined |
Bedaquiline | Not determined | Not determined |
Multi drug resistance | 91.2 (87.8-94.6) | 98.4 (97.2-99.6) |
Extremely drug resistance | 75.9 (64.5-87.3) | 98.4 (97.3-99.5) |
Lineage2 | Location | Strain | RD type |
lineage1 | Indo-Oceanic | EAI | RD239 |
lineage1.1 | Indo-Oceanic | EAI3;EAI4;EAI5;EAI6 | RD239 |
lineage1.1.1 | Indo-Oceanic | EAI4;EAI5 | RD239 |
lineage1.1.1.1 | Indo-Oceanic | EAI4;ZERO | RD239 |
lineage1.1.2 | Indo-Oceanic | EAI3;EAI5 | RD239 |
lineage1.1.3 | Indo-Oceanic | EAI6 | RD239 |
lineage1.2 | Indo-Oceanic | EAI1;EAI2 | RD239 |
lineage1.2.1 | Indo-Oceanic | EAI2 | RD239 |
lineage1.2.2 | Indo-Oceanic | EAI1 | RD239 |
lineage2 | East-Asian | Beijing | RD105 |
lineage2.1 | East-Asian (non-Beijing) | None | None |
lineage2.2 | East-Asian (Beijing) | Beijing-RD207 | RD105;RD207 |
lineage2.2.2 | East-Asian (Beijing) | Beijing-RD105/RD207 | RD105;RD207 |
lineage2.2.1 | East-Asian (Beijing) | Beijing-RD181 | RD105;RD207;RD181 |
lineage2.2.1.2 | East-Asian (Beijing) | Beijing-RD142 | RD105;RD207;RD181;RD142 |
lineage2.2.1.1 | East-Asian (Beijing) | Beijing-RD150 | RD105;RD207;RD181;RD150 |
lineage3 | East-African-Indian | CAS | RD750 |
lineage3.1 | East-African-Indian | Non-CAS1-Delhi | RD750 |
lineage3.1.1 | East-African-Indian | CAS1-Kili | RD750 |
lineage3.1.2 | East-African-Indian | CAS;CAS2 | RD750 |
lineage3.1.2.1 | East-African-Indian | CAS2 | RD750 |
lineage3.1.2.2 | East-African-Indian | CAS | RD750 |
lineage4 | Euro-American | LAM;T;S;X;H | None |
lineage4.1 | Euro-American | T;X;H | None |
lineage4.1.2 | Euro-American (X-type) | T;H | None |
lineage4.1.2.1 | Euro-American (X-type) | T1;H1 | RD182 |
lineage4.1.1 | Euro-American (X-type) | X1;X2;X3 | None |
lineage4.1.1.2 | Euro-American (X-type) | X1 | None |
lineage4.1.1.1 | Euro-American (X-type) | X2 | RD183 |
lineage4.1.1.3 | Euro-American (Haarlem) | X1;X3 | RD193 |
lineage4.2 | Euro-American | H;T;LAM | None |
lineage4.2.2 | Euro-American (Ural) | T;LAM7-TUR | None |
lineage4.2.2.1 | Euro-American | LAM7-TUR | None |
lineage4.2.1 | Euro-American (TUR) | H3;H4 | None |
lineage4.3 | Euro-American (LAM) | mainly-LAM | None |
lineage4.3.1 | Euro-American (LAM) | LAM9 | None |
lineage4.3.3 | Euro-American (LAM) | LAM;T | RD115 |
lineage4.3.4 | Euro-American (LAM) | LAM | RD174 |
lineage4.3.4.1 | Euro-American (LAM) | LAM1;LAM2 | RD174 |
lineage4.3.4.2 | Euro-American (LAM) | LAM1;LAM4;LAM11 | RD174 |
lineage4.3.4.2.1 | Euro-American (LAM) | LAM11 | RD174 |
lineage4.3.2 | Euro-American (LAM) | LAM3 | None |
lineage4.3.2.1 | Euro-American (LAM) | LAM3 | RD761 |
lineage4.4 | Euro-American | S;T | None |
lineage4.4.2 | Euro-American | T1;T2 | None |
lineage4.4.1 | Euro-American (S-type) | S;T | None |
lineage4.4.1.2 | Euro-American | T1 | None |
lineage4.4.1.1 | Euro-American | S;Orphans | None |
lineage4.5 | Euro-American | H;T | RD122 |
lineage4.6 | Euro-American | T;LAM | None |
lineage4.6.1 | Euro-American (Uganda) | T2 | RD724 |
lineage4.6.1.1 | Euro-American | T2-Uganda | RD724 |
lineage4.6.1.2 | Euro-American | T2 | RD724 |
lineage4.6.2 | Euro-American | T;LAM | RD726 |
lineage4.6.2.1 | Euro-American | T3 | RD726 |
lineage4.6.2.2 | Euro-American (Cameroon) | LAM10-CAM | RD726 |
lineage4.7 | Euro-American (mainly T) | T1;T5 | None |
lineage4.8 | Euro-American (mainly T) | T1;T2;T3;T5 | RD219 |
lineage4.9 | Euro-American (H37Rv-like) | T1 | None |
lineage5 | West-Africa 1 | AFRI_2;AFRI_3 | RD711 |
lineage6 | West-Africa 2 | AFRI_1 | RD702 |
lineage7 | Lineage 7 | None | None |
lineageBOV | M. bovis | BOV_1;BOV_2 | None |